SCHEMBL14083920

SCHEMBL14083920

CCOc1cccc(NC(=O)c2ccc(-c3ncccc3Cl)cc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 4/20 0.60
▸ NPC1 O15118 4/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ RECQL P46063 2/20 0.55
▸ TP53 P04637 2/20 0.54
▸ MAPT P10636 1/20 0.54
▸ KMT2A Q03164 4/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ PLAU P00749 1/20 0.53
▸ LMNA P02545 3/20 0.53
▸ NR1H4 Q96RI1 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ MEN1 O00255 3/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083465 0.89 TRPV1 (0.63) TRPV1NPC1RAB9ATP53MAPT
SCHEMBL14084034 0.88 GRM4 (0.48) TRPV1NPC1RAB9ATP53MAPT
SCHEMBL14083893 0.88 TRPV1 (0.61) TRPV1NPC1RAB9ATP53MAPT
SCHEMBL14083898 0.88 TRPV1 (0.70) TRPV1NPC1RAB9ATP53MAPT
SCHEMBL14083880 0.86 RAB9A (0.60) TRPV1NPC1RAB9AMAPTKMT2A
SCHEMBL14083838 0.85 SMN1; SMN2 (0.52) NPC1RAB9ARECQLTP53MAPT
SCHEMBL14083718 0.85 KMT2A (0.52) NPC1RAB9ARECQLTP53MAPT
SCHEMBL3874650 0.84 TRPV1 (0.65) TRPV1NPC1RAB9AMAPTHTT
SCHEMBL3885110 0.83 TRPV1 (0.66) TRPV1NPC1RAB9ATP53KMT2A
SCHEMBL14083475 0.83 TRPV1 (0.65) TRPV1NPC1RAB9AMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885NPC1 1061/4885RAB9A 1914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback